Please find enclosed herewith a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular dated July 13, 2023, an update on our wholly owned subsidiary company Glenmark Pharmaceuticals INC., USA relating to settlement agreement with U.S. Department of Justice.